neratinib maleate

Spain

Drugs containing this active substance

  • NERLYNX 40 MG FILM-COATED TABLETS

    It is used to treat patients with early-stage breast cancer who are hormone receptor-positive (HR-positive) and have HER2 overexpression or amplification (HER2-positive), and who have previously received treatment with trastuzumab less than one year ago.

    Form: tablets, film-coated

    Active substance Dosage
    neratinib maleate 48,31 mg

    ATC: L01E L01EH L01EH02

    Manufacturer: Pierre Fabre Medicament